Advanced Proteome Therapeutics Corporation

APTCF · OTC
Analyze with AI
7/31/2022
7/31/2021
7/31/2020
7/31/2019
Operating Activities
Net Income$597-$1,920-$541-$461
Dep. & Amort.$5$3$3$4
Deferred Tax$0$1,187-$60-$492
Stock-Based Comp.$0$132$28$81
Change in WC$301-$13$70$161
Other Non-Cash-$1,597$66$34$22
Operating Cash Flow-$694-$545-$467-$686
Investing Activities
PP&E Inv.-$14-$2$0-$1
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0-$48$0$0
Investing Cash Flow-$14-$50$0-$1
Financing Activities
Debt Repay.$197$48$0$135
Stock Issued$150$1,367$251$548
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$82$0$87$0
Financing Cash Flow$429$1,415$337$683
Forex Effect$0$0$0$0
Net Chg. in Cash-$278$820-$130-$4
Supplemental Information
Beg. Cash$822$2$132$136
End Cash$544$822$2$132
Free Cash Flow-$707-$547-$467-$687
Advanced Proteome Therapeutics Corporation (APTCF) Financial Statements & Key Stats | AlphaPilot